Grip Strength as a Biomarker of Aging
One of the simplest, cheapest measurements in medicine — a few seconds of squeezing a dynamometer — and at the same time one of the best-confirmed indicators in large cohort studies of overall physiological reserve and mortality risk, statistically stronger than systolic blood pressure alone.
Number of studies
3
Safety
Requires caution
Time to effects
Not applicable in the sense of an intervention — this is a diagnostic test. Changes in grip strength in response to resistance training tend to be measurable after 8-12 weeks of regular exercise, and the natural age-related declining trend is best tracked at 6-12 month intervals.
Who it's for
Table of contents
TL;DR
One of the simplest, cheapest measurements in medicine — a few seconds of squeezing a dynamometer — and at the same time one of the best-confirmed indicators in large cohort studies of overall physiological reserve and mortality risk, statistically stronger than systolic blood pressure alone.
- →One of the best-confirmed simple biomarkers of overall health risk and mortality in the literature, based on data from hundreds of thousands of participants across many countries
- →A stronger statistical predictor of overall and cardiovascular mortality than systolic blood pressure in the PURE study
- →A key diagnostic criterion for sarcopenia under international guidelines (EWGSOP2), correlating better with functional consequences than muscle mass alone
| Measurement type | Maximum isometric grip strength, measured with a hand dynamometer |
|---|---|
| Most commonly used device | Jamar hydraulic dynamometer — the gold standard in clinical research |
| Measurement time | A few seconds per trial, usually 2-3 trials per hand |
| Evidence level | Strong — one of the best-validated biomarkers in cohort studies of hundreds of thousands of participants |
| Clinical use | Diagnostic criterion for sarcopenia (EWGSOP2); geriatric and perioperative risk assessment |
| Status | A simple, low-cost screening test — available without a prescription, no lab tests needed |
Understand
Overview
Grip strength is a measurement of the maximum isometric force a person can generate while squeezing a hand dynamometer. At first glance it looks like a very narrow measurement — how much force someone's hand has — but decades of epidemiological research on hundreds of thousands of participants have shown that this simple, few-second test is one of the best-confirmed, most widely replicated biomarkers of overall health and mortality risk available to preventive medicine today. This isn't a niche or experimental measurement — it's part of routine geriatric assessment in many countries and one of the diagnostic criteria for sarcopenia under international guidelines (EWGSOP2, Asian Working Group for Sarcopenia).
The most compelling evidence for the importance of this measurement is the PURE study (Prospective Urban Rural Epidemiology) published in The Lancet in 2015 — one of the largest, broadest cohort analyses in the history of preventive medicine, covering nearly 140,000 participants from 17 countries at different income levels. The result was striking enough to enter the canon of aging literature: every 5 kg drop in grip strength was associated with a 16% higher risk of death from all causes, and grip strength turned out to be a stronger predictor of overall and cardiovascular mortality than systolic blood pressure — a parameter treated as one of the foundations of risk assessment in preventive medicine.
Why does measuring the strength of one hand say something so universal about the whole body? The answer lies in the concept of physiological reserve. Grip strength isn't an isolated trait of just the forearm muscles — it's a product of the integrity of the entire neuromuscular system (the number and quality of motor units, nerve conduction speed, and the mass and quality of muscle tissue), which degrades with age in a way correlated with the degradation of other body systems. A person with high grip strength in old age usually also has better-preserved cardiovascular, respiratory, metabolic, and cognitive function — not because a strong hand "protects" these systems, but because all these systems age to some extent in parallel, and grip strength is simply the easiest-to-measure external window into that shared process.
History of use
Grip strength measurement as an indicator of overall physical condition has been used in medicine and anthropometry since at least the early 20th century, but for a long time it was treated mainly as a marker of local hand function, useful e.g. in orthopedics and rehabilitation after injury. The breakthrough came in recent decades of the 20th and early 21st century, when large, long-running cohort studies (such as British birth cohort studies and North American aging studies) began systematically showing that grip strength measured in middle age predicts not only future physical disability, but also all-cause mortality, independent of other risk factors. The culmination of this research direction was the PURE study published in The Lancet in 2015, which, thanks to its enormous, global sample (nearly 140,000 participants from 17 countries), firmly established grip strength as one of the most strongly confirmed simple biomarkers of aging in the medical literature, alongside measurements like VO2max or gait speed.
Mechanism of action
Grip strength is the result of three main physiological components that together determine how much isometric force a hand can generate while squeezing a dynamometer: the integrity of innervation of the forearm and hand muscles (the number and function of motor units, the speed of nerve impulse conduction from the spinal cord), the mass and quality of muscle tissue (both fiber size and the degree of fatty and connective tissue infiltration, which worsens contraction quality independent of mass itself), and the neuromuscular system's ability to synchronously, coordinately activate the relevant muscle groups in the short time of the test.
With age, all three components undergo gradual degradation in a process called sarcopenia. The number of motor units in skeletal muscles begins measurably declining from around age 50, and the rate of this decline accelerates after age 60–65. At the same time, selective loss of type II muscle fibers (fast, responsible for generating large force in a short time) occurs to a greater extent than loss of type I fibers (slow, endurance-oriented), which partly explains why the decline in maximum strength with age tends to be proportionally greater than the decline in muscular endurance.
Why does this local, single-hand process correlate so strongly with the risk of events affecting the whole body, including the heart, brain, and overall mortality? The leading hypothesis treats grip strength not as a cause of these events, but as a surrogate marker (proxy) for overall physiological reserve and the burden of systemic aging processes, including chronic low-grade inflammation (inflammaging), mitochondrial dysfunction, and cellular damage accumulation — processes that simultaneously degrade skeletal muscle, blood vessel, heart muscle, and nerve tissue function. A person with rapidly declining grip strength likely also has faster, parallel decline in these other systems — hence grip strength statistically "captures" a signal that actually comes from many simultaneously occurring aging processes, not just from the muscles of the hand itself.
Motor unit activation
The brain and spinal cord recruit motor units in the forearm and hand muscles to generate maximum isometric contraction while squeezing the dynamometer.
Nerve conduction
The signal reaches muscle fibers via motor neurons — the speed and integrity of this conduction worsens with age as denervation progresses.
Muscle fiber contraction
The force of the generated contraction depends on the number, size, and type (I vs II) of available muscle fibers and the degree of their fatty and connective tissue infiltration.
Force registration by the dynamometer
The device measures the resulting isometric force in kilograms or kilograms-force (kgf), usually taking the best of several trials.
Interpretation against population norms
The result is compared against norms adjusted for age, sex, and sometimes height, to assess whether it falls within the expected range or signals possible sarcopenia or elevated health risk.
Evidence: strong — based on 3 studies in this database.
Benefits
Common myths
MythGrip strength only tells you about hand strength and is only relevant for people doing manual physical work.
FactData from the PURE study and many other large cohorts show that grip strength is a statistical marker of overall physiological reserve, correlating with risk of death, cardiovascular events, and stroke independent of the type of work performed or lifestyle.
MythMuscle mass itself is more important than grip strength — if you have a lot of muscle, grip strength has no added diagnostic value.
FactSarcopenia data show the opposite of this intuition: grip strength correlates more strongly with functional consequences (falls, loss of independence) than muscle mass itself measured e.g. by DXA, which is why it became the main screening criterion in the EWGSOP2 guidelines.
MythThe age-related decline in grip strength is inevitable and can't be influenced.
FactRegular resistance training, adequate protein intake, and overall physical activity can significantly slow the rate of grip strength decline associated with sarcopenia — one reason resistance training is recommended as a preventive intervention in aging, not just an aesthetic one.
Forms & variants
Grip Strength as a Biomarker of Aging comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Hydraulic dynamometer (Jamar)
The gold standard used in most clinical and cohort studies — high precision and repeatability, with adjustable grip position suited to hand size.
Best for: Clinical measurements, scientific research, and tracking a precise trend over time
Spring dynamometer
A cheaper, more portable alternative with slightly lower measurement precision than the hydraulic type, but still useful for screening assessment and self-monitoring at home.
Best for: Self-monitoring of grip strength trends at home on a limited budget
Electronic/digital dynamometer
Newer devices with digital readout and sometimes the ability to save measurement history in an app — convenient for self-tracking, with precision comparable to hydraulic types depending on the model.
Best for: People who want to systematically track their result in an app or health journal
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
The standard clinical protocol uses a hydraulic dynamometer (usually Jamar type) — the person sits with the arm at the side of the torso, elbow bent at 90 degrees, and squeezes the device with maximum force for a few seconds. 2-3 trials are performed per hand (dominant and non-dominant), with a short break between trials, and the best result obtained is used for analysis.
Norms vary between studies, guidelines, and depending on age, sex, and sometimes height, but the EWGSOP2 guidelines use approximate thresholds below 27 kg for men and below 16 kg for women as a signal of possible sarcopenia requiring further evaluation — it's worth interpreting the result in the context of the full population norm for that age, not a single rigid threshold.
In the PURE study (Lancet, 2015, n=139,691), grip strength turned out to be a stronger statistical predictor of overall and cardiovascular mortality than systolic blood pressure — this doesn't mean blood pressure has no clinical significance (it does, and is a modifiable risk factor with established interventions), but that grip strength as a single, simple measurement had somewhat higher predictive power for these specific endpoints in this large, global cohort.
Regular resistance training, including exercises targeting grip strength specifically (e.g. deadlifts, hanging from a bar, dumbbell exercises), usually improves the dynamometer result within a few months. Grip strength, however, is treated mainly as a marker (proxy) of overall physiological reserve, not as an isolated cause of risk — improving the dynamometer result alone through narrowly targeted forearm exercises, without improving overall physical condition, won't necessarily translate 1:1 into risk reduction to the degree the observational correlation would suggest. General whole-body resistance training is a more sensible strategy than isolated grip training.
Most of the data and the greatest practical clinical significance concern people over 50-60, where the test is used for early detection of sarcopenia and geriatric risk assessment. In younger people, the measurement is used mainly in rehabilitation, orthopedics, and sports research, where it has other, more specific applications than assessing general aging-related risk.
Standard clinical protocols recommend measuring both hands, taking the higher of the two results for analysis (this most often, though not always, corresponds to the dominant hand). The difference between hands can itself be informative — a very large asymmetry may suggest a local neurological or orthopedic problem, not just general fitness level.
Spring and digital dynamometers available for home purchase give useful results for tracking your own trend over time, but usually have somewhat lower precision and repeatability than the reference hydraulic Jamar-type dynamometer used in clinical studies — for comparisons with population norms from scientific literature, measurement with the same type of device used in the reference study is most reliable.
Dosage & timing
Typical dose
Pomiar wykonuje się 2–3 razy na każdą rękę (dominującą i niedominującą), z przerwą między próbami, biorąc najlepszy uzyskany wynik jako wartość referencyjną
Form
Dynamometr hydrauliczny (najczęściej typu Jamar) — złoty standard w badaniach klinicznych; dostępne są też tańsze dynamometry sprężynowe o nieco mniejszej precyzji
To test diagnostyczny/przesiewowy, nie interwencja — nie ma dawkowania w sensie suplementacyjnym. Regularne powtarzanie pomiaru (np. raz na 6–12 miesięcy po 50. roku życia) pozwala śledzić trend w czasie, który bywa informacyjnie ważniejszy niż pojedynczy wynik.
Best times to take it
- The measurement is best performed under similar conditions when repeated (similar time of day, before intense hand-involving training, not immediately after physical exertion), to ensure comparability of results over time
- In geriatric patients, the measurement is often part of routine, periodic functional assessment (e.g. at checkups every six months to a year)
Safety
Side effects & contraindications
Possible side effects
The measurement itself is non-invasive and safe — carries no health risk
During very intense, maximal effort, people with uncontrolled hypertension may experience a momentary rise in blood pressure during the trial — usually not clinically significant, but worth noting in cardiology patients
The result may be understated by current pain, hand joint inflammation (e.g. osteoarthritis, rheumatoid arthritis), or previous wrist injuries, independent of overall body condition
Contraindications
Acute injury, fracture, or inflammation of the hand/wrist — the measurement should be postponed until healed, to avoid distorting the result and worsening the injury
Very uncontrolled, severe hypertension — worth consulting a doctor before performing maximal isometric effort
Interactions
Pain or hand joint disease (arthritis, carpal tunnel syndrome) can artificially lower the result independent of overall muscle strength — worth accounting for in interpretation
The dominant hand usually generates a slightly higher result than the non-dominant one — standard measurement protocols account for this by measuring both hands
Time of day and hydration status can slightly affect the result — for longitudinal comparisons it's worth measuring under similar conditions
Is it worth taking?
Who it's for
- People over 50-60 as an early warning sign of possible sarcopenia and loss of independence
- Geriatric patients as part of routine assessment of functional, perioperative, and hospitalization risk
- People with chronic diseases (kidney failure, COPD, cancer), where grip strength serves as a marker of cachexia and physiological reserve
- Anyone interested in a simple, well-validated indicator of their functional health status, without needing lab tests
Not for
- Acute injury, fracture, or inflammation of the hand/wrist — the measurement should be postponed until healed, to avoid distorting the result and worsening the injury
- Very uncontrolled, severe hypertension — worth consulting a doctor before performing maximal isometric effort
Evidence
Worth knowing
Every 5 kg drop in grip strength was associated with a 16% increase in all-cause mortality risk in the PURE study.
Grip strength turned out to be a stronger predictor of mortality and cardiovascular events than systolic blood pressure in this study.
Low grip strength is one of the main diagnostic criteria for sarcopenia under the EWGSOP2 guidelines.
The number of functioning motor units in skeletal muscle begins measurably declining from around age 50.
Studies
Every 5 kg decrease in grip strength was associated with a 16% increase in all-cause mortality risk (HR 1.16; 95% CI 1.13-1.20) — grip strength turned out to be a stronger predictor of mortality and cardiovascular events than systolic blood pressure.
Leong DP et al., PURE study, The Lancet, 2015
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
Strong evidenceLeong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A et al. · The Lancet · 2015
One of the largest cohort analyses in the history of grip strength research — 139,691 participants from 17 countries at different income levels, followed for a median of 4 years. Every 5 kg drop in grip strength was associated with a 16% increase in all-cause mortality risk (HR 1.16; 95% CI 1.13-1.20), a 17% increase in cardiovascular and non-cardiovascular mortality risk, and higher risk of heart attack and stroke. Grip strength turned out to be a stronger predictor of overall and cardiovascular mortality than systolic blood pressure. Measurement was performed with a Jamar dynamometer on both hands.
View studySarcopenia: revised European consensus on definition and diagnosis (EWGSOP2)
Strong evidenceCruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al. · Age and Ageing · 2019
Updated international guidelines from the European Working Group on Sarcopenia in Older People, establishing low grip strength as the main screening criterion for sarcopenia, with approximate thresholds below 27 kg for men and below 16 kg for women. The document summarizes evidence that grip strength correlates more strongly with the functional consequences of sarcopenia (falls, disability) than muscle mass measured by imaging methods alone.
View studyGrip strength across the life course: normative data from twelve British studies
Strong evidenceDodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM et al. · PLOS ONE · 2014
An analysis of data from 12 British cohort studies (over 49,000 participants total) establishing reference normative values for grip strength by age and sex in the British population, widely cited as a reference point in clinical and epidemiological research on aging and sarcopenia.
View studySources & bibliography
- Leong et al. 2015 — The Lancet (PURE study)
- Cruz-Jentoft et al. 2019 — Age and Ageing (EWGSOP2)
- Dodds et al. 2014 — PLOS ONE
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
205 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
269 publications on this site
Related entries
4.9Strength Training
One of the single strongest predictors of healthy aging — it shapes muscle mass, bone density, and insulin sensitivity.
4.8VO2 max
The maximum amount of oxygen the body can take up during exercise — one of the strongest, well-documented predictors of lifespan, measurable in a sports diagnostics lab.
4.1Intrinsic Capacity
A World Health Organization (WHO) concept defining 'true' functional aging as the sum of five domains of physical and mental ability — an alternative to molecular biomarkers, assessed in a clinical exam rather than a lab.
4.7HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
4.7Why is insulin high despite normal glucose?
Elevated insulin with normal fasting glucose is most often compensatory hyperinsulinemia — the pancreas produces more insulin to keep glucose normal despite the tissues' weaker response. It's an early warning sign that the HOMA-IR index can catch long before glucose itself ever rises.
4.6Can insulin resistance occur in a lean man?
Yes — insulin resistance can affect men with a normal BMI too, if fat accumulates mainly viscerally and inside internal organs rather than under the skin. We explain the TOFI phenomenon (thin-outside-fat-inside) and why BMI alone isn't enough to assess metabolic risk.
4.6Can high insulin lower SHBG?
Yes — insulin directly suppresses SHBG production in the liver, making chronically elevated insulin one of the best-documented causes of low SHBG. This is an important bridge between insulin resistance and the interpretation of testosterone results, in both men and women.
4.5Can insulin resistance occur without being overweight?
Yes — insulin resistance can occur even in people with no excess body fat at all, including visceral fat. We explain the rarer, but real, mechanisms that operate independently of fat: genetic variants in the insulin signaling pathway, chronic sleep deprivation, chronic stress, and physical inactivity.
Related articles
Poradniki5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear
A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.
August 1, 2026
Badania naukoweWhat we now know about NMN and longevity — a review of human studies
NMN, a precursor of NAD+, has for years been one of the most hotly debated supplements in the biohacking community. We look at what the latest clinical trials in humans show, as distinct from earlier studies in mice.
August 11, 2026
Badania naukoweLongevity Vitamins: Which Supplements Actually Have Real Scientific Evidence Behind Them
Every supplement shelf promises a longer life in every capsule, but the hard data from large clinical trials tells a far more measured story. We go through which vitamins genuinely extend healthy lifespan in people with a real deficiency, and which — despite their popularity — have no supporting evidence at all, or worse, evidence of no benefit.
August 20, 2026
PoradnikiNMN vs NAD+ vs Resveratrol — What Actually Extends Life?
Three of the biggest names in longevity, one shared hypothesis, and a very different level of evidence in humans for each. An honest comparison of mechanism, clinical trial quality, and monthly cost — with no marketing rounding up.
August 20, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.